en · de · es · fr · pt
sr9009-notes.peptides4088.com › Guide › Background And Receptor Mechanism — Reference Sheet

Background And Receptor Mechanism — Reference Sheet

By Editorial Desk · published 2026-01-31 · last reviewed 2026-03-19 · Guide

If you have been reading about circadian rhythm and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-03-19. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Receptor Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.

At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.

Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.

SR9009 Handling and Quality Control

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small moleculeStudied as a REV-ERB agonist
Molecular formulaC20H24ClN3O4SReported for the neutral compound
AppearanceOff-white to pale yellow solidTypical research-grade material
SolubilitySparingly soluble in waterSoluble in solvents such as DMSO
Common synonymsSR9009; StenabolicStenabolic is an informal alias

Detection, Regulation, and Misconceptions

Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.

Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.

Related pages on this site

Handling, Analysis, and Regulation

Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.

Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.

SR9009 Background and Mechanism

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

Notes from published material

=== Nonlinearity === The Navier–Stokes equations are nonlinear partial differential equations in the general case and so remain in almost every real situation. In some cases, such as one-dimensional flow and Stokes flow (or creeping flow), the equations can be simplified to linear equations. The nonlinearity makes most problems difficult or impossible to solve and is the main contributor to the turbulence that the equations model. The nonlinearity is due to convective acceleration, which is an acceleration associated with the change in velocity over position. Hence, any convective flow, whether turbulent or not, will involve nonlinearity. An example of convective but laminar (nonturbulent) flow would be the passage of a viscous fluid (for example, oil) through a small converging nozzle. Such flows, whether exactly solvable or not, can often be thoroughly studied and understood.

== Ecology == The Rotheca myricoides interacts with several other species. Pseumenes depressus, the Asian hornet, and Xylocopa ruficeps all visit the Rotheca myricoides. Xylocopa phalothorax, Xylocopa tranquebarorum, and Xylocopa nasalis eat the Rotheca myricoides. The plant plays a significant role in its native ecosystems by supporting pollinators like butterflie and bees. Its long corolla tubes are adapted to attract specific pollinators with long proboscises for effective pollen transfer. The plant provides food to birds that consume its drupes, helping in seed dispersal. The status on the Red List of South African plants is at "Least Concern" as assessed on 2005/06/30, as it was not highlighted as a potential taxa for conservation concern.

=== Associated conditions === Women with PMOS have an increased risk of a range of metabolic, cardiovascular, reproductive and mental health conditions. The likelihood of developing metabolic disorders is about three to seven times higher than in women without PMOS. Insulin resistance is common, even in lean women with PMOS. Overweight or obese women with PMOS are at higher risk of type 2 diabetes than women without PMOS at the same BMI. Lean women with PMOS do not appear to be at higher risk of developing diabetes. Other metabolic and cardiovascular complications commonly associated with PMOS include:

Sources: en.wikipedia.org

Background from the literature

The Gβγ subunit is essential for the formation of heterotrimeric G protein through its association with the Gα subunit allowing the G proteins coupling to the GPCR. Therefore, any agent inhibiting the Gβγ subunits signalling effects must not interfere with the heterotrimeric G protein formation or Gα subunit signalling. Gβγ expression is universal throughout almost all the cells of the body so any agent acting to inhibit this subunit could elicit numerous side effects. Small molecule inhibitors that target the coupling of Gβγ to specific effectors and do not interfere with normal G protein cycling/ heterotrimeric formation, have the potential to work as therapeutic agents in treating some specific diseases.

== Philanthropy == Rush actively participated in philanthropic causes. The band were one of several hometown favourites to play Molson Canadian Rocks for Toronto, also dubbed SARStock, at Downsview Park in Toronto on July 30, 2003, with an attendance of over half a million people. The concert benefited the Toronto economy after the SARS outbreaks earlier in the year. The band has continued to be interested in promoting human rights. They donated $100,000 to the Canadian Museum for Human Rights after a concert they held in Winnipeg, Manitoba on May 24, 2008. On July 24, 2013, Rush performed a benefit concert in Red Deer, Alberta at the ENMAX Centrium, with all proceeds going to the Canadian Red Cross to help victims of the 2013 flooding that devastated many regions of southern Alberta. The original venue for the show, the Scotiabank Saddledome in Calgary was heavily damaged from the flooding and was unavailable for the concert date as originally planned. In 2015 Rush was awarded the Juno Allan Waters Humanitarian Award. Individual members of Rush have also been a part of philanthropic causes. Hughes & Kettner, zenTera, and TriAmp electronics have been endorsed and used by Lifeson for many years. A custom signature amplifier was engineered by Lifeson and released in April 2005 with the stipulation that UNICEF receive a $50 donation for every Alex Lifeson Signature TriAmp sold.

The 82nd Division was redesignated on 13 February 1942 as Division Headquarters, 82nd Division, and ordered into active service on 25 March 1942, at Camp Claiborne, Louisiana, under the command of Major General Omar N. Bradley. The officer and enlisted cadre mostly came from the 9th Infantry Division. The enlisted men came from reception centers in the Midwest, South, and Southwest. During this period, the division brought together three officers who would ultimately steer the US Army during the following two decades: Matthew Ridgway, James M. Gavin, and Maxwell D. Taylor. Under Major General Bradley, the 82nd Division's Chief of staff was George Van Pope. On 15 August 1942, the 82nd Infantry Division, now commanded by Major General Ridgway, became the first airborne division in the history of the US Army, and was redesignated as the 82nd Airborne Division. The 82nd was selected after deliberations by the US Army General Staff because of a number of factors. It was not a Regular Army or National Guard unit, its personnel had all completed basic training, and it was stationed in an area that had good weather and flying facilities. Historian John B. Wilson wrote that "many traditionalists in those components wanted nothing to do with such an experimental force". James M. Gavin wrote that many states would refuse the conversion of their National Guard units, likely because of the additional expenses needed to maintain facilities for airborne units. The division initially consisted of the 325th, 326th and 327th Infantry Regiments, and supporting units.

Sources: en.wikipedia.org

Reference notes

Rick Tomato Genetics Resource Center maintains a gene bank of wild relatives, monogenic mutants and genetic stocks. Research on processing tomatoes is also conducted by the California Tomato Research Institute in Escalon, California. In California, growers have used a method of cultivation called dry-farming, especially with Early Girl tomatoes. This technique encourages the plant to send roots deep to find existing moisture.

== Epidemiology == The first cases of yellow fever occurred in early September, but the first blood samples for confirmation were not sent to the Institut Pasteur reference laboratory in Dakar, Senegal until 30 October. On 9 November, WHO Sudan reported 266 suspected cases and 85 deaths for a case fatality rate of 32%. Most cases were in Central Dafur state (51.5 percent, reported in March 2013), but the outbreak later expanded to the four other states of North Darfur (21 percent), West Darfur (17.4 percent) and South Darfur (9.5 percent), including refugee camps related to the ongoing war in Darfur. Laboratory confirmation of yellow fever came on 13 November. Most of the cases were among nomads, which contributed to the rapid spread. According to newspaper reports, about 10 000 workers from the gold mines of Jebel Amer fled to Nyala, the capital of South Darfur, after more than 60 deaths in the gold mining area. One newspaper reported: "The spread of the disease in South Darfur is a disaster and the epidemic requires organizations and the international community to address the disease and provide enough vaccines to vaccinate all citizens of the state." Hundreds of patients had accumulated at the Nyala Teaching Hospital, some sleeping outside, and there was a shortage of medical personnel and supplies. By early December the number of deaths had reached 164. Health authorities in China began scanning travelers and Chinese citizens returning from Sudan. As many as a million Chinese workers are employed in oil, mining and construction in Africa.

== Pharmacological effects == Adenosine is an endogenous purine nucleoside that modulates many physiological processes. Cellular signaling by adenosine occurs through four known adenosine receptor subtypes (A1, A2A, A2B, and A3). Extracellular adenosine concentrations from normal cells are approximately 300 nM; however, in response to cellular damage (e.g., in inflammatory or ischemic tissue), these concentrations are quickly elevated (600–1,200 nM). Thus, in regard to stress or injury, the function of adenosine is primarily that of cytoprotection preventing tissue damage during instances of hypoxia, ischemia, and seizure activity. Activation of A2A receptors produces a constellation of responses that in general can be classified as anti-inflammatory. Enzymatic production of adenosine can be anti-inflammatory or immunosuppressive.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.

Is SR9009 a SARM?

No. SR9009 is frequently mislabeled as a SARM in online discussions, but it does not target androgen receptors. Its known mechanism involves REV-ERB nuclear receptors and circadian-metabolic gene regulation.

What human data exist for SR9009?

Human clinical data are very limited. There is no approved human use, and safety and efficacy in people are not established. Most evidence comes from preclinical models, so effects observed in animals may not apply to humans.

How is SR9009 detected in samples?

Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.

Network